Amol Akhade, Senior Consultant at Fortis Hospitals Mumbai, shared on LinkedIn:
“Read the title of the paper. Read the title of editorial. See the graph.
And then decide yourself.
Do we need MECD for ‘early ‘ detection of ‘early stage’ cancer or for ‘early ‘ detection of ‘late stage’ cancer?
NEJM Your answer is as good as mine.”
Read the full article.
Title: Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Authors: Peter Sasieni, Peter Johnson, Thomas Round, Jane Warwick, Helen Jones, Saoirse Dolly, Lennard Lee, D.Phil., Yujin Lee, Harpal Kumar, Wei Liang, Rebecca Smittenaar, Richard D. Neal, Charles Swanton
Other articles featuring Amol Akhade on OncoDaily.